Published :
Tables : 63
Figures : 53
Category : Healthcare
No. of Pages : 235
Report Code : HC-U3356
Bone Growth Stimulator Market is poised to value over USD 1.64 billion by 2027 end with a CAGR of over 5.2% during the forecast period 2020 to 2027. The increased preference of patients for minimally and non-invasive surgical procedures, rising patient population and advantages of performing bone stimulator procedures for treating bone fractures are some of the crucial factors contributing to the growth of the market. Furthermore, a rising geriatric population across the world has increased the number of patients diagnosed with arthritis as these individuals are more prone to disorders like gouty arthritis and osteoarthritis. According to a report provided by the Arthritis Foundation, over 45 million Americans were diagnosed with arthritis in 2015, and it is predicted that this number shall reach over 80 million by 2040. Such a rise in the number of arthritic patients shall boost the bone growth stimulator market growth. There has been a significant rise in the number of accident and trauma related cases causing bone fractures. As per the Centre for Disease Control and Prevention, over 40 million people in the United States are admitted for traumatic injury emergencies every year. Some of the road accidents and trauma related injuries can cause damage to the spine or delayed non-union and union fractures that are required to be surgically treated. These bone stimulator devices are used for healing bones during a failed spinal fusion treatment, delays in the union of fresh bone fractures with the application of electrical or ultrasonic current to the site of the bone that requires to be fused. The research and development activities related to bone stimulation has recently increased owing to the provision of investments by government bodies. For instance, the American Academy of Orthopaedic Surgeons, the North American Spine Foundation are major contributors in the development of devices and implants for spinal treatments by conducting different training programs for physicians across the world and by providing finds for research and development. Furthermore, many key players are introducing novel bone growth stimulators in the market that are economic and can be used for minimally invasive surgeries. For instance, Orthofix Inc., a company based in Texas has launched two new bone growth stimulators, the SpinalStim and the CervicalStim. These have been approved by the U.S FDA as well as the European CE Mark. They have also developed an application, Stim onTrack, that provides physicians with data in real-time, thereby enabling the effective detailing of the treatment protocol of the patient. All these factors shall increase the bone growth stimulator market demand substantially. Market Segmentation: By Product • Bone Growth Stimulation Devices • Bone Morphogenetic Proteins • Platelet Rich Plasma By Application • Spinal Fusion Surgeries • Delayed Union and Non-Union Fractures • Oral and Maxillofacial Surgeries • Others By End User • Hospitals and Clinics • Home Care • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is fragmented into product, application, end user and region. The product segment is categorised into bone morphogenetic proteins, platelet-rich plasma, implanted bone growth stimulators, ultrasonic bone growth stimulators, external bone growth stimulators, capacity coupling devices. The external bone growth stimulators segment held the largest bone growth stimulator market share owing to the increased insistence for bone healing surgical treatments that are non-invasive. Additionally, these devices are lightweight, portable, powered by batteries and are easy to handle thereby increasing the adoption of these device by patients. Additionally, the availability of novel products like CMF SpinaLogic Bone Growth Stimulators and CMF OL1000 Bone Growth Stimulators shall augment the growth of the market substantially. The application segment is bifurcated into spinal fusion surgeries, delayed union and non-union bone fractures, oral and maxillofacial surgeries and others. The spinal fusion surgeries dominate the market, and this can be attributed to a rise in the prevalence of spinal cord injuries like spinal stenosis, herniated discs and fractures. As per the World Health Organization, over 300,000 people get their spinal cord injured every year either due to violence, falls or road accidents. The geriatric population, who are more prone of getting a bone fracture, is consistently rising. As per the U.S Census Bureau, over 615 million people were above the age of 65 in 2015 and it is expected that this number will reach 1 billion by 2030. Such a surge in the geriatric population shall increase the demand for such products and surgeries across the world. Regional Analysis: The North America region subjugated the market, and this is due to increase in the number of patients diagnosed with vertebral fractures or osteoporosis. As per the Association of Neurological Surgeons, over 7.8 million women in the United States are diagnosed with osteoporosis and over 25% of women are predicted to be diagnosed with vertebral compression fractures. The Asia Pacific region, however, is predicted to grow at a remarkable rate during the forecast period with the rising number of trauma and road accident cases. As per the report provided by the World Road Statistics, over 500,000 road accidents were reported in 2015 in India, with the rise of over 1.3% from 2014. Such a high patient number shall promote the usage of bone stimulator devices. Competitive Landscape: The key market players included are Orthofix Holdings Inc., Medtronic, Zimmer Biomet, DJO Global Inc., Bioventus LLC, Stryker, DePuy Synthes, Arthrex Inc., Isto Biologics, Terumo BCT Inc. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global bone growth stimulators market by product, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The increased preference of patients for minimally and non-invasive surgical procedures, rising patient population and advantages of performing bone stimulator procedures for treating bone fractures are some of the crucial factors contributing to the growth of the market. Furthermore, a rising geriatric population across the world has increased the number of patients diagnosed with arthritis as these individuals are more prone to disorders like gouty arthritis and osteoarthritis. According to a report provided by the Arthritis Foundation, over 45 million Americans were diagnosed with arthritis in 2015, and it is predicted that this number shall reach over 80 million by 2040. Such a rise in the number of arthritic patients shall boost the bone growth stimulator market growth. There has been a significant rise in the number of accident and trauma related cases causing bone fractures. As per the Centre for Disease Control and Prevention, over 40 million people in the United States are admitted for traumatic injury emergencies every year. Some of the road accidents and trauma related injuries can cause damage to the spine or delayed non-union and union fractures that are required to be surgically treated. These bone stimulator devices are used for healing bones during a failed spinal fusion treatment, delays in the union of fresh bone fractures with the application of electrical or ultrasonic current to the site of the bone that requires to be fused. The research and development activities related to bone stimulation has recently increased owing to the provision of investments by government bodies. For instance, the American Academy of Orthopaedic Surgeons, the North American Spine Foundation are major contributors in the development of devices and implants for spinal treatments by conducting different training programs for physicians across the world and by providing finds for research and development. Furthermore, many key players are introducing novel bone growth stimulators in the market that are economic and can be used for minimally invasive surgeries. For instance, Orthofix Inc., a company based in Texas has launched two new bone growth stimulators, the SpinalStim and the CervicalStim. These have been approved by the U.S FDA as well as the European CE Mark. They have also developed an application, Stim onTrack, that provides physicians with data in real-time, thereby enabling the effective detailing of the treatment protocol of the patient. All these factors shall increase the bone growth stimulator market demand substantially.
Market Segmentation:
By Product • Bone Growth Stimulation Devices • Bone Morphogenetic Proteins • Platelet Rich Plasma By Application • Spinal Fusion Surgeries • Delayed Union and Non-Union Fractures • Oral and Maxillofacial Surgeries • Others By End User • Hospitals and Clinics • Home Care • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is fragmented into product, application, end user and region. The product segment is categorised into bone morphogenetic proteins, platelet-rich plasma, implanted bone growth stimulators, ultrasonic bone growth stimulators, external bone growth stimulators, capacity coupling devices. The external bone growth stimulators segment held the largest bone growth stimulator market share owing to the increased insistence for bone healing surgical treatments that are non-invasive. Additionally, these devices are lightweight, portable, powered by batteries and are easy to handle thereby increasing the adoption of these device by patients. Additionally, the availability of novel products like CMF SpinaLogic Bone Growth Stimulators and CMF OL1000 Bone Growth Stimulators shall augment the growth of the market substantially. The application segment is bifurcated into spinal fusion surgeries, delayed union and non-union bone fractures, oral and maxillofacial surgeries and others. The spinal fusion surgeries dominate the market, and this can be attributed to a rise in the prevalence of spinal cord injuries like spinal stenosis, herniated discs and fractures. As per the World Health Organization, over 300,000 people get their spinal cord injured every year either due to violence, falls or road accidents. The geriatric population, who are more prone of getting a bone fracture, is consistently rising. As per the U.S Census Bureau, over 615 million people were above the age of 65 in 2015 and it is expected that this number will reach 1 billion by 2030. Such a surge in the geriatric population shall increase the demand for such products and surgeries across the world.
Regional Analysis:
The North America region subjugated the market, and this is due to increase in the number of patients diagnosed with vertebral fractures or osteoporosis. As per the Association of Neurological Surgeons, over 7.8 million women in the United States are diagnosed with osteoporosis and over 25% of women are predicted to be diagnosed with vertebral compression fractures. The Asia Pacific region, however, is predicted to grow at a remarkable rate during the forecast period with the rising number of trauma and road accident cases. As per the report provided by the World Road Statistics, over 500,000 road accidents were reported in 2015 in India, with the rise of over 1.3% from 2014. Such a high patient number shall promote the usage of bone stimulator devices.
Competitive Landscape:
The key market players included are Orthofix Holdings Inc., Medtronic, Zimmer Biomet, DJO Global Inc., Bioventus LLC, Stryker, DePuy Synthes, Arthrex Inc., Isto Biologics, Terumo BCT Inc.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global bone growth stimulators market by product, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Bone Growth Stimulator Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Bone Growth Stimulation Devices 7.1.1 External Bone Growth Stimulators 7.1.1.1 Combined Magnetic Field Devices 7.1.1.2 Capacitive Coupling Devices 7.1.1.3 Pulsed Electromagnetic Field Devices 7.1.2 Implanted Bone Growth Stimulators 7.1.3 Ultrasonic Bone Growth Stimulators 7.2 Bone Morphogenetic Proteins 7.3 Platelet Rich Plasma 8. Bone Growth Stimulator Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Spinal Fusion Surgeries 8.2 Delayed Union and Non-Union Fractures 8.3 Oral and Maxillofacial Surgeries 8.4 Others 9. Bone Growth Stimulator Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 9.1 Hospitals and Clinics 9.2 Home Care 9.3 Others 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 10.2.1. U.S. 10.2.2. Canada 10.2.3. Mexico 10.2.4. Rest of North America 10.3 Market Size (USD Mn) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5 Switzerland 12.2.6. Spain 12.2.7. Russia 12.2.8. Poland 12.2.9. Rest of Western Europe 12.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 Japan 13.2.2 China 13.2.3 Singapore 13.2.4 Korea 13.2.5 India 13.2.6 Australia and New Zealand 13.2.7 ASEAN 13.2.8 Rest of Asia Pacific 13.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1 Introduction 14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 14.2.1 UAE 14.2.2 South Africa 14.2.3 Egypt 14.2.4 Saudi Arabia 14.2.5 Rest of MEA 14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 15.1 Orthofix Holdings Inc. 15.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2 Medtronic 15.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3 Zimmer Biomet 15.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4 DJO Global Inc. 15.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Bioventus LLC 15.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Stryker 15.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7 DePuy Synthes. 15.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8 Arthrex Inc. 15.8.1. Company Overview (HQ, Business Segments, Employee Strength) 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9 Isto Biologics 15.9.1. Company Overview (HQ, Business Segments, Employee Strength) 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10 Terumo BCT Inc. 15.10.1. Company Overview (HQ, Business Segments, Employee Strength) 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 16. Impact of COVID-19 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. Competitive Intelligence and Competitive Matrix 17.1 Competitive Intelligence 17.2 Competitive Matrix 18. Major Deals and Strategic Alliances Analysis 18.1 Joint ventures 18.2 Mergers and acquisitions 18.3 Licensing and partnerships 18.4 Technology Collaborations 18.5 Strategic Divestments 18.6 Market Entry Strategies 19. Relevant Case Studies and Latest News Updates 20. Research Sources and List of Primary Contacts of this Study 21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics